Smart Bet, Only Option, or Both?: Pharma R&D turns to AI  

Session details:

Join us as we unveil groundbreaking research on how AI is transforming biopharma R&D. Our study of 500 senior executives reveals that 82% believe AI will fundamentally reshape drug discovery and development, with generative AI driving major gains in efficiency and innovation. 
We’ll share key findings, explore real-world use cases, and invite perspectives from leading pharma organizations on scaling AI for impact. Don’t miss this discussion on the future of R&D and patient care.